FILE:PFE/PFE-8K-20030331162740.txt.gz
EVENTS:	Acquisition or disposition of assets
TEXT:
ITEM: Acquisition or disposition of assets
 
Item 2. Acquisition or Disposition of Assets
The sale of Pfizer's Adams confectionary business to Cadbury Schweppes plc for $4.2 billion in cash closed on March 31, 2003. The sale was a negotiated, arms-length transaction. Pfizer's press release is included as Exhibit 99 and is incorporated by reference.
 
Item 7. Exhibits
Exhibit 99 - Press Release of Pfizer Inc.
dated March 31, 2003.
 
Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.
 
By: s/ Margaret M. Foran
Margaret M. Foran
Title: Vice President-Corporate Governance
and Secretary
 
 
Dated: March 31, 2003

EXHIBIT 99
 
For immediate release Contact: Bob Fauteux
March 31, 2003 +1 212 573-3079
Colette Goldrick +44 (20) 7654-1704
NEW YORK, March 31 - Pfizer Inc said today it has completed the sale, announced December 17, 2002, of its Adams confectionary business for $4.2 billion in cashto Cadbury Schweppes plc
.
"Our Adams colleagues contributed significantly to Warner-Lambert and Pfizer over the past 40 years, and we are grateful to them," said Hank McKinnell, Pfizer chairman and chief executive officer. "We wish them continued success as they now join Cadbury Schweppes."
For the Adams sale, Merrill Lynch and Lazard assisted Pfizer as investment bankers; Cadwalader, Wickersham & Taft provided legal counsel.
Pfizer Inc discovers, develops, manufactures and markets leading prescription medicines for humans and animals and many of the world's best-known consumer brands.
 
 
 
 


